One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Veterinary Drugs Market

[ 英語タイトル ] Veterinary Drugs Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0089157
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 115
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Bayer AG
- Zoetis Inc.
- Virbac S.A
- Boehringer Ingelheim International GmbH (Merial)
- Elanco
- Ceva
- Vetoquinol S.A
- Bimeda, Inc (Bimeda Holdings PLC)
- Merck & Co., Inc.

[Report Description]

Veterinary drugs are the drugs used in the treatment of numerous diseases growing in animals. Veterinary drugs such as antibiotics, antimicrobials, antihistamines, antiprotozoals and hormones are developed in order to minimize the attack of harmful virus and bacterial parasites in animals.

According to American Pet Products Association (APPA), 67% percent of United States households own a pet and estimated that 78 million dogs and 85.8 million cats are owned in the United States. Therefore the presence of advanced cost-effective veterinary drugs and rising clinical animal researches are the key driving factors in the veterinary drug market.

Key Market Trends

Parasiticides Segment is Expected to be a Fastest Growing Segment in the Veterinary Drugs Market

Parasites are organisms that survive by attacking pets and farm animals for nourishment and live in or on the body, benefiting from food and protection. Common parasites such as ticks, mosquitos and fleas live outside the body on the skin or hidden in an animal’s fur which not only harm the animal, they can quickly spread a disease outbreak. For instance, the Rift Valley Fever is an endemic zoonotic disease in Africa and the Middle East that costs producers USD 427 million every year.

Hence, owing to aforementioned factors, along with rise in prevalence of infectious diseases and increase in pet ownership, the parasiticides segment hold a significant market share and is anticipated to show similar trend over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global veterinary drugs market due to a rise in the prevalence of infectious diseases and the emergence of new technologies in this region. North America held the highest share and is also expected to continue dominating the market through the forecast period. Moreover, the introduction of new animal-related products and increasing adoption of animals is fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The veterinary drug market is moderately consolidated and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Bayer AG, Zoetis Animal Healthcare, Virbac S.A, Boehringer Ingelheim International GmbH, Ceva, Vetoquinol S.A, Merck Ltd, Elanco, Intervet Inc and Bimeda, Inc

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Assumptions
1.2 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Prevalence of Infectious Diseases
4.2.2 Emergence of New Technologies, especially in Biologics
4.3 Market Restraints
4.3.1 Lack of Veterinarians​
4.3.2 Use of Counterfeit Medicines​
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product Type
5.1.1 Anti-infectives
5.1.2 Anti-inflammatory
5.1.3 Parasiticides
5.1.4 Vaccines
5.1.5 Other Types
5.2 By Route of Administration
5.2.1 Oral
5.2.2 Parenteral
5.2.3 Topical
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Zoetis Inc.
6.1.3 Virbac S.A
6.1.4 Boehringer Ingelheim International GmbH (Merial)
6.1.5 Elanco
6.1.6 Ceva
6.1.7 Vetoquinol S.A
6.1.8 Bimeda, Inc (Bimeda Holdings PLC)
6.1.9 Merck & Co., Inc.




Recommended reports